Showing 1 - 10 of 15
Persistent link: https://www.econbiz.de/10010421600
Persistent link: https://www.econbiz.de/10012663313
Persistent link: https://www.econbiz.de/10014229272
Over the last decade, generic penetration in the U.S. pharmaceutical market has increased substantially, providing significant gains in consumer surplus. What impact has this rise in generic penetration had on the rate and direction of early stage pharmaceutical innovation? We explore this...
Persistent link: https://www.econbiz.de/10013032342
Even though management consultants increasingly recommend that in-house research be outsourced, little is known about the conditions favoring substitution or complementarity between internal R&D and external technology acquisition. In this paper, we attempt to provide a deeper understanding of...
Persistent link: https://www.econbiz.de/10014178802
Even though management consultants increasingly recommend that in-house research be outsourced, little is known about the conditions favoring substitution or complementarity between internal R&D and external technology acquisition. In this paper, we attempt to provide a deeper understanding of...
Persistent link: https://www.econbiz.de/10013064588
Persistent link: https://www.econbiz.de/10009722826
Persistent link: https://www.econbiz.de/10003324533
Persistent link: https://www.econbiz.de/10003551065
Over the last decade, generic penetration in the U.S. pharmaceutical market has increased substantially, providing significant gains in consumer surplus. What impact has this rise in generic penetration had on the rate and direction of early stage pharmaceutical innovation? We explore this...
Persistent link: https://www.econbiz.de/10012458133